chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye disorder, Guillain-Barre syndrome, Headache, Herpes zoster, Hypoaesthesia
Clinical narrative: developed a stye in my eye (note the blisters and stye were both on the same side); fever blisters developed in my mouth and around my lips; strange head ache; face and scalp were sensitive to touch; arm hurt; was slightly numb; This is a spontaneous report from a non-contactable consumer (Patient).  A 47-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 05:45 as single dose for covid-19 immunisation. Medical history included autoimmune disease, asthma, diabetic, heart condition (palpitations) and known allergies for gluten. Concomitant medication included ascorbic acid, herbal NOS, levoglutamide, lysine, magnesium, manganese, retinol, riboflavin, selenium, tocopherol, zin (AIRBORNE), fish oil, elderberry [sambucus nigra], garlic [allium sativum] and VITAMIN D. Patient received no other vaccine in four weeks. Other vaccine in two weeks included airborne, garlic, elderberry, vitamin d, fish oil. Patient did not experience covid prior vaccination. Patient has not been covid tested post vaccination. On 05Mar2021 at 06:00 PM after getting vaccine, the patient experienced had arm hurt and was slightly numb, the next evening she had strange headache where face and scalp were sensitive to touch, next day fever blisters developed in her mouth and around lips. The patient took 2 doses of Benadryl and felt better the next day, the following day she developed a stye in eye (the blisters and stye were both on same side that she received the shot). Other events except "next day fever blisters developed in her mouth and around lips" were not treated. The clinical outcome of events was resolving.                                                No follow-up attempt are possible. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immune system disorder, Magnetic resonance imaging, Neuropathy peripheral, Oral mucosal blistering, Pain in extremity
Clinical narrative: developed a stye in my eye (note the blisters and stye were both on the same side); fever blisters developed in my mouth and around my lips; strange head ache; face and scalp were sensitive to touch; arm hurt; was slightly numb; This is a spontaneous report from a non-contactable consumer (Patient).  A 47-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 05:45 as single dose for covid-19 immunisation. Medical history included autoimmune disease, asthma, diabetic, heart condition (palpitations) and known allergies for gluten. Concomitant medication included ascorbic acid, herbal NOS, levoglutamide, lysine, magnesium, manganese, retinol, riboflavin, selenium, tocopherol, zin (AIRBORNE), fish oil, elderberry [sambucus nigra], garlic [allium sativum] and VITAMIN D. Patient received no other vaccine in four weeks. Other vaccine in two weeks included airborne, garlic, elderberry, vitamin d, fish oil. Patient did not experience covid prior vaccination. Patient has not been covid tested post vaccination. On 05Mar2021 at 06:00 PM after getting vaccine, the patient experienced had arm hurt and was slightly numb, the next evening she had strange headache where face and scalp were sensitive to touch, next day fever blisters developed in her mouth and around lips. The patient took 2 doses of Benadryl and felt better the next day, the following day she developed a stye in eye (the blisters and stye were both on same side that she received the shot). Other events except "next day fever blisters developed in her mouth and around lips" were not treated. The clinical outcome of events was resolving.                                                No follow-up attempt are possible. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paralysis, Product dose omission issue, Transient ischaemic attack
Clinical narrative: developed a stye in my eye (note the blisters and stye were both on the same side); fever blisters developed in my mouth and around my lips; strange head ache; face and scalp were sensitive to touch; arm hurt; was slightly numb; This is a spontaneous report from a non-contactable consumer (Patient).  A 47-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: EN6206), via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 05:45 as single dose for covid-19 immunisation. Medical history included autoimmune disease, asthma, diabetic, heart condition (palpitations) and known allergies for gluten. Concomitant medication included ascorbic acid, herbal NOS, levoglutamide, lysine, magnesium, manganese, retinol, riboflavin, selenium, tocopherol, zin (AIRBORNE), fish oil, elderberry [sambucus nigra], garlic [allium sativum] and VITAMIN D. Patient received no other vaccine in four weeks. Other vaccine in two weeks included airborne, garlic, elderberry, vitamin d, fish oil. Patient did not experience covid prior vaccination. Patient has not been covid tested post vaccination. On 05Mar2021 at 06:00 PM after getting vaccine, the patient experienced had arm hurt and was slightly numb, the next evening she had strange headache where face and scalp were sensitive to touch, next day fever blisters developed in her mouth and around lips. The patient took 2 doses of Benadryl and felt better the next day, the following day she developed a stye in eye (the blisters and stye were both on same side that she received the shot). Other events except "next day fever blisters developed in her mouth and around lips" were not treated. The clinical outcome of events was resolving.                                                No follow-up attempt are possible. No further information expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Constipation, Fatigue, Feeling cold, Headache
Clinical narrative: General flu-ish feeling; headache; fatigue; chills; extreme cold (freezing) hands and feet followed by fever; fever; extreme constipation lasted 6 days.; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 28Feb2021 at 15:15 as single dose for COVID-19 immunization. Vaccination facility: Public Health Clinic. Medical history included wrist injury and allergy to Oxycodone, which was taken after wrist surgery. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 07Feb2021at 13:00 as single dose for COVID-19 immunization. Patient did not receive any other vaccine in four weeks and no other medications in two weeks prior vaccination. Patient not diagnosed with COVID-19 prior vaccination. On 01Mar2021 (next day of vaccination), patient experienced general flu-ish feeling, headache, fatigue, chills, extreme cold (freezing) hands and feet followed by fever. Fatigue, slight headache and extreme constipation lasted 6 days. No treatment was received for the events. The patient was not tested for Covid post vaccination. The outcome for all the events was recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: General flu-ish feeling; headache; fatigue; chills; extreme cold (freezing) hands and feet followed by fever; fever; extreme constipation lasted 6 days.; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 28Feb2021 at 15:15 as single dose for COVID-19 immunization. Vaccination facility: Public Health Clinic. Medical history included wrist injury and allergy to Oxycodone, which was taken after wrist surgery. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in left arm on 07Feb2021at 13:00 as single dose for COVID-19 immunization. Patient did not receive any other vaccine in four weeks and no other medications in two weeks prior vaccination. Patient not diagnosed with COVID-19 prior vaccination. On 01Mar2021 (next day of vaccination), patient experienced general flu-ish feeling, headache, fatigue, chills, extreme cold (freezing) hands and feet followed by fever. Fatigue, slight headache and extreme constipation lasted 6 days. No treatment was received for the events. The patient was not tested for Covid post vaccination. The outcome for all the events was recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling face; This is a spontaneous report from a non-contactable consumer (patient) reported for herself. An unspecified age non pregnant female patient received bnt162b2 (PFIZER- BIONTECH COVID- 19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration, in Left Arm on 27Feb2021 as 1ST DOSE, SINGLE for Covid-19 immunisation in workplace clinic. The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not receive other vaccines in four weeks of vaccination. The patient did not receive other medications within two weeks of vaccination. The patient was not diagnosed with COVID, prior vaccination. Since vaccination, the patient was not tested positive for COVID. On 27Feb2021 at 3:00 PM, the patient had experienced tingling face. The patient did not receive treatment for the event. The outcome of the event was recovered on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number can not be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: This is a spontaneous report from a contactable consumer. A 59-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6202), via an unspecified route of administration, administered on left arm on 02Mar2021 16:15 (at the age of 59-years-old) as a single dose for COVID-19 immunization. Medical history included hypertension, hypothyroidism, fibromyalgia, depression, seasonal allergy (pollen), allergy to animal dander, dust allergy. The patient had not received any other vaccines in four weeks. Concomitant medications included lisinopril, duloxetine, levothyroxine and fexofenadine hydrochloride (ALLEGRA). The patient had no other vaccine within four weeks. Prior to the vaccination, it was unknown, whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 14:00, the patient experienced vertigo and nausea. The patient did not receive any treatment. Outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Myalgia
Clinical narrative: Fatigue; muscle pain; chest pain; This is a spontaneous report from a contactable consumer or other non hcp.   A 27-years-old female (pregnant unknown) patient received bnt162b2 (BNT162B2, solution for injection, Lot Number: EL3249), via an unspecified route of administration, administered in right arm on 10Mar2021 09:30 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included pulmonary embolism, asthma. Concomitant medication included albuterol (salbutamol) taken for an unspecified indication.  Patient had no known allergies. The patient did not receive any other vaccines in four weeks and any other medications in two weeks. Patient was not tested for covid prior or post vaccination. On 10Mar2021 15:00, the patient experienced fatigue, muscle pain, chest pain. The clinical outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, SARS-CoV-1 test
Clinical narrative: I have fever 38.5C,  2.5 weeks after taking vaccine.; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for himself that a 28-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EN6200), dose 1 via an unspecified route of administration, administered in Arm Left on 18Feb2021 12:00 as 1ST DOSE, SINGLE dose for covid-19 immunisation. Medical history included Diamond Black fan anaemia; Hepatitis C (Cured). Concomitant medications included ashwagandha (ASHWAGANDHA); bacopa monnieri (BACOPA [BACOPA MONNIERI]). Patient had no known allergies. On 10Mar2021, the patient experienced fever 38.5c, 2.5 weeks after taking vaccine. Patient did not received any treatment. The patient underwent lab tests and procedures which included nasal swab test: unknown on 10Mar2021; Body temperature 38.5C on 10Mar2021. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. Patient did not visit to physician office. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain, Pyrexia
Clinical narrative: Flu like symptoms; whole body aches; fever; tiredness; This is a spontaneous report from a contactable nurse. A 20-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), via an unspecified route of administration on an unknown date in Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient not been tested for COVID-19. The patient experienced flu like symptoms, whole body aches, fever, tiredness on an unknown date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain, SARS-CoV-1 test, Vaccination site pain
Clinical narrative: Injection site soreness; fatigue; body aches; nausea; This is a spontaneous report from a contactable consumer (patient). A 30-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EN6206) via an unspecified route of administration, administered in Arm Left on 10Mar2021 at 17:15 (at the age of 30-years-old) as single dose for covid-19 immunisation. The patient's medical history includes known allergies shellfish, endometriosis, pelvic floor myalgia, depression, PMDD and asthma. The patient underwent lab tests and procedures which included sars-cov-1 test: negative on 28Feb2021 Nasal swab. The patient's concomitant medications included acetaminophen, ibuprofen, ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) and melatonin. It was reported that on 10Mar2021 at 18:00, the patient experienced injection site soreness, fatigue, body aches and nausea. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Skin infection, Tendon pain
Clinical narrative: Pain in left achilles tendon and left knee. No swelling, just throbbing pain.; Pain in left achilles tendon and left knee. No swelling, just throbbing pain.; Skin infection under right breast; This is a spontaneous report from a contactable other healthcare professional (patient). This 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 19Feb2021 11:45 (at the age of 45-year-old) (Lot Number: EL9267) as single dose for COVID-19 immunisation. The patient was not pregnant. The patient did not receive other vaccines in four weeks. Relevant medical history included asthma, hypertension, herpes simplex type II, psoriasis, latex allergy and sulfa allergy. Past drug history included allergy to lisinopril and pethidine hydrochloride (DEMEROL). Concomitant medications included beclometasone dipropionate (QVAR), fluticasone propionate (FLONASE), levocetirizine, amlodipine and olmesartan, all taken for unspecified indications, start and stop dates were not reported. On 27Feb2021, the patient experienced pain in left Achilles tendon and left knee. No swelling, just throbbing pain. On 27Feb2021, she experienced also skin infection under right breast. All the events were considered as non-serious. The events resulted in Doctor or other healthcare professional office/clinic visit. Corrective treatments taken as a result of the events included "boot on L foot, clotrimazole and betamethasone skin". The patient was recovering from the events. The patient did not have COVID-19 prior to vaccination, and she was not tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain
Clinical narrative: Fatigue; Tender lymph nodes near site of injection; This is a spontaneous report from a non-contactable other health care professional reporting for herself. A 36-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in right arm on 04Mar2021 09:00 (at the age of 36-year-old) as single dose for COVID-19 immunization. The patient medical history included diabetes mellitus and Sjogren's syndrome from an unknown date and unknown if ongoing. Patient had not any allergies. Concomitant medications included metformin, ibuprofen and paracetamol (TYLENOL)-all taken for an unspecified indication, start and stop date were not reported. Patient did not have COVID prior to the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. On Mar2021 (as reported: 02Mar2021 21:00) the patient experienced fatigue, and tender lymph nodes near site of injection. The patient did not receive the treatment for adverse events. The outcome of events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Ultrasound scan
Clinical narrative: Swollen lymph node in groin area- appeared 3 days after vaccine.; This is a spontaneous report from a non-contactable consumer (reported for herself, patient). This 31-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration in left arm on 06Mar2021 12:45 PM, as a single dose for Covid-19 immunization(age at vaccination 31years). The patient did not have any medical history or known allergies. Concomitant medications in two weeks included Zoloft Oral solution, Cetirizine Hydrochloride (ZYRTEC), Fluticasone Propionate (FLONASE), Ethinylestradiol, Norethisterone Acetate (MICROGESTIN), and SPIRONOLACTO. On 09Mar2021 18:00, 03 days after vaccine, the patient experienced swollen lymph node in groin area appeared. The event lead to a Doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccine in four weeks of suspect vaccine. The patient was not having Covid prior vaccination and was not tested for it post vaccination. The patient underwent treatment Exam (unspecified) and ultrasound scan. The outcome of the event of swollen lymph node in groin area was reported as resolving.  No follow-up attempts were possible; information about lot/batch number could not be obtained.  No further information was expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Headache, Nervousness
Clinical narrative: dizziness; fever; chills; nervousness; Headache; sleepiness/drowsiness; shaking; diarrhea; This is a spontaneous report from a contactable consumer (the patient).   A 40-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 06Mar2021 16:00 (Batch/Lot Number: Pfizer EL9267) as single dose for covid-19 immunisation (Age at vaccination 40 years) .  Medical history included penicillin hypersensitivity. Concomitant medications included ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported.  On 13Feb2021 the patient received the first dose of BNT162B2 vaccine (Lot #Pfizer EN5318). The patient experienced dizziness  on 07Mar2021 09:00 with outcome of recovering , fever  on 07Mar2021 09:00 with outcome of recovering , chills on 07Mar2021 09:00 with outcome of recovering , nervousness  on 07Mar2021 09:00 with outcome of recovering , headache  on 07Mar2021 09:00 with outcome of recovering , sleepiness/drowsiness  on 07Mar2021 09:00 with outcome of recovering , shaking  on 07Mar2021 09:00 with outcome of recovering , diarrhea on 07Mar2021 09:00 with outcome of recovering.   The patient received paracetamol (TYLENOL), increased fluid intake and bed rest as treatment of the events.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Somnolence, Tremor
Clinical narrative: dizziness; fever; chills; nervousness; Headache; sleepiness/drowsiness; shaking; diarrhea; This is a spontaneous report from a contactable consumer (the patient).   A 40-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 06Mar2021 16:00 (Batch/Lot Number: Pfizer EL9267) as single dose for covid-19 immunisation (Age at vaccination 40 years) .  Medical history included penicillin hypersensitivity. Concomitant medications included ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported.  On 13Feb2021 the patient received the first dose of BNT162B2 vaccine (Lot #Pfizer EN5318). The patient experienced dizziness  on 07Mar2021 09:00 with outcome of recovering , fever  on 07Mar2021 09:00 with outcome of recovering , chills on 07Mar2021 09:00 with outcome of recovering , nervousness  on 07Mar2021 09:00 with outcome of recovering , headache  on 07Mar2021 09:00 with outcome of recovering , sleepiness/drowsiness  on 07Mar2021 09:00 with outcome of recovering , shaking  on 07Mar2021 09:00 with outcome of recovering , diarrhea on 07Mar2021 09:00 with outcome of recovering.   The patient received paracetamol (TYLENOL), increased fluid intake and bed rest as treatment of the events.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoglycaemia, Hypotension, Pruritus, Rash
Clinical narrative: During his 30 minute waiting period after the injection, the patient began to experience itching; Systemic reaction (hypoglycemia, hypotension, generalized rash); Systemic reaction (hypoglycemia, hypotension, generalized rash); Systemic reaction (hypoglycemia, hypotension, generalized rash); This is a spontaneous report from a non-contactable Other Healthcare Professional reporting for a patient. A 78-years-old male patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206) via an unknown route of administration on an unknown date as first dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, during his 30 minute waiting period after the injection, the patient began to experience itching and the differential diagnosis was systemic reaction (hypoglycemia, hypotension, generalized rash). Patient complained of itching of skin (chronic vs new itching). It was reported that patient denied rash, difficulty breathing, difficulty swallowing, wheezing, throat tightness, lightheadedness, dizz. Patient denies chills, fever, malaise/fatigue, facial swelling, sore throat, frequent throat clearing, cough, chest tightness, shortness of breath, wheezing, rash, hives, eczema, dizziness and headache facial swelling, lip swelling and tongue swelling. Patient was discharge as stable to go home and follow up with PCP. Patient reported immediately upon getting back to the bay that he doesn't think it's anything but his chronic itching that he gets. Patient declines feeling like this is an allergic response like he had in the past. Benadryl given as requested. The outcome of the events was unknown.  No follow-up attempts were possible. No further information was expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Weight
Clinical narrative: arm soreness; This is a spontaneous report from a contactable consumer or other non-HCP (patient, self-reporting). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9264 and expiration date was not reported), via an unspecified route of administration in left arm on 09Feb2021 14:00 (at the age of 71-year-old) as first dose, single for COVID-19 immunisation. The patient medical history included quadruple bypass/ coronary artery bypass in 2014, blood pressure abnormal, blood cholesterol, anxiety, supplementation therapy all from an unknown date and unknown if ongoing. Concomitant medications included Metoprolol Tartrate 25mg twice daily beta blocker prescribed after bypass surgery for her heart rate to be low in 2014, losartan 25mg daily for blood pressure and has been taking for 2-3 years. She takes it for her blood pressure due to having white coat syndrome. Atorvastatin 80mg daily into the left arm for cholesterol and has been taking for maybe 7 years, aspirin 325mg daily following bypass surgery in 2014, Bupropion XL 50mg daily for anxiety in Jun2020 and Centrum Silver Women once daily four times a week for supplement in 2020 all of which are ongoing. On 09Feb2021, the patient reported that her arm was sore the same evening of getting the first dose. It lasted through the night. It hurt if she rolled over on it. The next morning it was barely sore. She called her doctor in Jun2020 and told him she was in a funk. The doctor said everyone was having anxiety. She was prescribed Bupropion XL. She takes other vitamins but declines to provide details. No history of previous immunization with the Pfizer vaccine considered as suspect nor any additional vaccines administered on same date of the Pfizer Suspect. The patient received the second dose of the Covid-19 vaccine on 02Mar2021. The patient underwent lab test which showed weight between 200-204 lbs on Feb2021. Outcome of the event was resolved on 02Mar2021.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chest discomfort, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Shortness of breath; Chest tightness; burning; This is a spontaneous report from a contactable consumer (Patient). A 22-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6199), via an unspecified route of administration, administered in right arm on 09Mar2021 (at the age of 22-years-old), as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EK4176), via an unspecified route of administration, administered in right arm on 16Feb2021 at 12:00 as single dose for COVID-19 immunisation. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID-19 prior vaccination. On 09Mar2021 at 08:00 (same day of vaccination), patient experienced shortness of breath, chest tightness and burning. Patient did not receive any treatment for adverse events. The patient underwent lab tests and procedures which included SARS-CoV-2 antibody test: unknown results (Nasal Swab) on an unspecified date. Patient has not been tested for COVID-19 post vaccination. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen, painful lymph in armpit region in the same arm shot was received.; Swollen, painful lymph in armpit region in the same arm shot was received.; This is a spontaneous report from a contactable Consumer.   A 25-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 09Mar2021 15:00 (Batch/Lot Number: EN6206) (at the age of 25) as single dose for covid-19 immunisation. Medical history included hypothyroidism. No known allergies. First dose was administered on 16Feb2021 15:00 right arm (lot# EL8982). Concomitant medications included levothyroxine taken for an unspecified indication, bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, sertraline taken for an unspecified indication. The patient experienced swollen, painful lymph in armpit region in the same arm shot was received on 11Mar2021. No covid tested post vaccination. No covid prior vaccination. No treatment received. The outcome was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: pain at injection site; Fever; exhaustion; This is a spontaneous report from a contactable consumer (patient).   A 40-years-old female patient received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Right on 09Mar2021 15:00 (Batch/Lot number was not reported) (at the age of 40) as single dose for covid-19 immunisation. First dose was received on 16Feb2021, left arm, 02:45PM. No other vaccine was received in four weeks. No covid prior vaccination. No covid tested post vaccination.  Medical history included asthma, iodine allergy. Concomitant medication included gabapentin taken for an unspecified indication, start and stop date were not reported. The patient experienced pain at injection site on 10Mar2021 13:00, fever on 10Mar2021 13:00, exhaustion on 10Mar2021 13:00. No treatment received. The outcome was not recovered.    No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: fatigue; Headache; fever; chills; This is a spontaneous report from a contactable consumer  An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Unknown if Covid prior vaccination. Unknown if Covid tested post vaccination. The patient experienced fatigue on 10Mar2021, headache on 10Mar2021, fever on 10Mar2021, chills on 10Mar2021. No treatment received. The outcome was recovered.    No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction; This is a spontaneous report from a contactable consumer.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced allergic reaction in Feb2021. Patient was told not to get the second dose of vaccine and wonders what her options are. It was unknown if treatment received. The outcome was unknown.    No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood pressure measurement
Clinical narrative: nurse told her mother that a "dear friend" also received the COVID-19 vaccine and "has the same blood pressure issues and cannot get it under control; This is a spontaneous report from a contactable consumer (patients daughter). A female patient of unspecified age received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient had the same blood pressure issues and cannot get it under control. Caller reported that patients dear friend also received the COVID-19 vaccine and had the same issue. The outcome of the event was unknown. Caller's husband reported that HCPs have seen this happened to other patient post-vaccination with the COVID-19 vaccine.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Memory impairment, Pain in extremity
Clinical narrative: Right leg bothering her; mind went blank and she was unable to think of her email address to provide; Arm soreness and arm soreness was getting worse/arm was sore; This is a spontaneous report from a contactable consumer (patient). An 83-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported), via an unspecified route of administration on 21Feb2021 as single dose for covid-19 immunisation (at the age of 83 years). The patient medical history and concomitant medications were not reported.  The patient experienced right leg bothering her and mind went blank and she was unable to think of her email address to provide on an unspecified date, arm soreness and arm soreness was getting worse/arm was sore on 21Feb2021. The patient received her first dose of the Covid-19 vaccine on 21Feb2021, and her arm was sore on the 21Feb2021 (that night) and on the 22Feb2021 (next day) but went away. The pain came back  two and a half weeks later, and her 2nd shot was scheduled for this 13Mar2021 (Saturday). It seemed like it was okay after the first two days, but now it was back. Her arm had been sore, all week; on 10Mar2021 (today) it was really sore. She also mentioned her right leg was bothering her (start date: unspecified), but she didn't think that's related to the vaccine. She did not know if it was like just really dull before and she did not really notice it. It seemed like it was okay, and all of a sudden, each day she felt a little sore and today was really sore. She confirmed after the vaccine she had arm soreness and the arm soreness was getting worse. On 13Mar2021 (Saturday), it would be 3 weeks since she received the first dose. She took ADVIL as treat-ment, and but it didn't seem to help (Usually, ADVIL helps her). She did have TYLENOL and wanted to know if you can alternate TYLENOL and ADVIL. While attempting to provide email she commented her mind went blank and she was unable to think of her email address to provide (start date: unspecified). In concern to height, she thought she had shrunk. She wanted to know if it was normal for the pain to come back after about 2 and a half, almost 3 weeks and since this arm was sore, will she have to get it in her other arm. Therapeutic measures were taken as a result of arm soreness and arm soreness was getting worse/arm was sore. The outcome for arm soreness and arm soreness was getting worse/arm was sore was not recovered, and for another event was unknown.  No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever; body ache; chills; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID -19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 2nd dose, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever, chills and body ache after second shot on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Hypomenorrhoea
Clinical narrative: Period is affected. Very light and crampy; Period is affected. Very light and crampy; This is a spontaneous report from a contactable consumer (patient herself). A 26-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm, on 03Mar2021 at 11:00 (at the age of 26 years old) as unknown, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. On 10Mar2021, it was reported that the patient's period was affected. She experienced very light and crampy, which was very uncommon for her. The patient's sister also had extremely heavy which was uncommon for her after the vaccine. The patient did not receive a treatment for the adverse events. The outcome of the events was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination.   Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site erythema
Clinical narrative: Fever; Chills; Injection site raised n red; This is a spontaneous report from a contactable consumer (patient). A 47-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on 09Mar2021 10:00 (Lot Number: Ep6955) (at 47 years old) as first dose, single dose for COVID-19 Immunization. Medical history included COVID-19 and known allergies: Cillins; both from an unknown date. The patient's concomitant medications were not reported. No other vaccine in four weeks. No covid test post vaccination. On 10Mar2021 07:00 PM, the patient experienced fever, chills and injection site raised and red. The outcome of the events was not recovered.   Follow-up attempts are completed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Swelling face
Clinical narrative: Swollen inner checks; Extreme arm pain; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 48-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number and expiration date not reported), via an unspecified route of administration on 11Mar2021 13:00 (at the age of 48-years-old) at 1st dose, single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were reported as none. The patient has no allergies to medications, foods, or other products. On 11Mar2021 23:00, the patient experienced swollen inner cheeks, extreme arm pain, and fatigue. The patient did not receive any treatment for the events. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, did not receive any other medications within 2 weeks of vaccination, has not been diagnosed with COVID-19 prior to vaccination, and has not been tested for COVID-19 since the vaccination. Outcome of all the events was reported as recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dyspepsia, Heart rate, Heart rate increased
Clinical narrative: Burning sensation in my heart area for about 24 hours; My resting heart rate increased to 107 beats per minute; My blood pressure  wich was elevated vs my normal level; This is a spontaneous report from a contactable healthcare professional (patient herself). A 62-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 09Mar2021 at 11:00 (Batch/Lot Number: EN6208) (at the age of 62-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included penicillin allergy, pollen allergy and allergic to cats. The patient's concomitant medications were not reported. Patient previously took codeine and experienced drug allergy. Prior to vaccination, patient was not diagnosed with COVID-19. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 09Mar2021 at 11:15 (about 15 minutes after receiving the vaccine), the patient's resting heart rate increased to 107 beats per minute. The patient alerted the medical personnel. They took her blood pressure which was elevated vs normal level, but oxygenation was normal. Heart rate returned to normal in about 5 minutes, but the patient experienced a burning sensation in her heart area for about 24 hours. Events resulted in doctor or other healthcare professional office/clinic visit. No treatment was given to the patient. Reporter assessed the events as non-serious. Since the vaccination, patient had not been tested for COVID-19. Outcome of burning sensation in heart was recovered on 10Mar2021, heart rate increased was recovered on 09Mar2021 11:20 and remaining event was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygenation index
Clinical narrative: Burning sensation in my heart area for about 24 hours; My resting heart rate increased to 107 beats per minute; My blood pressure  wich was elevated vs my normal level; This is a spontaneous report from a contactable healthcare professional (patient herself). A 62-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 09Mar2021 at 11:00 (Batch/Lot Number: EN6208) (at the age of 62-years-old) as first dose, single dose for COVID-19 immunisation. Medical history included penicillin allergy, pollen allergy and allergic to cats. The patient's concomitant medications were not reported. Patient previously took codeine and experienced drug allergy. Prior to vaccination, patient was not diagnosed with COVID-19. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 09Mar2021 at 11:15 (about 15 minutes after receiving the vaccine), the patient's resting heart rate increased to 107 beats per minute. The patient alerted the medical personnel. They took her blood pressure which was elevated vs normal level, but oxygenation was normal. Heart rate returned to normal in about 5 minutes, but the patient experienced a burning sensation in her heart area for about 24 hours. Events resulted in doctor or other healthcare professional office/clinic visit. No treatment was given to the patient. Reporter assessed the events as non-serious. Since the vaccination, patient had not been tested for COVID-19. Outcome of burning sensation in heart was recovered on 10Mar2021, heart rate increased was recovered on 09Mar2021 11:20 and remaining event was unknown.   Follow-up attempts are completed. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: GI distress started 18 hrs after dose.; This is a spontaneous report from a contactable consumer. A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6203 Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 06Mar2021 at 11:00 (at the age of 78 years old) as second dose, single for COVID-19 immunisation in a Clinic. Medical history included chronic obstructive pulmonary disease (COPD) and arthritis, both from an unknown date. The patient did not receive any other vaccines in 4 weeks and prior to vaccine the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot number: E69266), via an unspecified route of administration administered in left arm on 13Feb2021, (at the age of 78 years old) as first dose, single for COVID-19 immunisation. The patient experienced GI (gastrointestinal) distress started 18 hours after dose on 07Mar2021 at 05:00. No treatment was received for the adverse event. Since vaccination, the patient has not been tested for COVID-19. Outcome of the event was recovered on unspecified date in 2021.    No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metal taste in her mouth; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 60-year-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:00 (at the age of  60 years old) (Lot Number: El1283) as first dose, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine nor any other medication within 2 weeks of vaccination. On 10Mar2021 10:30 (also reported as 11:00), the patient had a metal taste in her mouth within 30mins of having vaccine lasting about 10 mins then shorter duration of metal taste on day 2. The patient did not receive any treatment for the event. Since the vaccination, has the patient not been tested for COVID-19. The outcome of the event was recovered.    No follow-up attempts are needed. No further information is expected.